Overview
Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH.
Indication
For the treatment of female infertility
Associated Conditions
- Secondary Hypogonadotrophic hypogonadism
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/03/26 | Phase 4 | Recruiting | Fundacion Clinic per a la Recerca Biomédica | ||
2022/10/07 | Phase 2 | Withdrawn | |||
2022/07/11 | Early Phase 1 | Completed | |||
2022/04/11 | Phase 4 | UNKNOWN | Instituto Bernabeu | ||
2021/01/22 | Not Applicable | UNKNOWN | Nanjing University | ||
2020/11/25 | Phase 4 | Completed | |||
2018/09/07 | Not Applicable | Completed | |||
2018/05/30 | Not Applicable | UNKNOWN | |||
2018/04/12 | Phase 4 | Completed | |||
2018/02/22 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| EMD Serono, Inc. | 44087-1150 | SUBCUTANEOUS | 250 ug in 0.5 mL | 12/26/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 2/2/2001 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| Ovidrel Solution for Injection 250 mcg | SIN13015P | INJECTION, SOLUTION | 250 mcg | 7/13/2004 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled syringe | 96037 | Medicine | A | 9/17/2003 | |
| OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen | 170446 | Medicine | A | 7/30/2010 |
Help Us Improve
Your feedback helps us provide better drug information and insights.